CC vs. ICL, AXTA, ESI, ALTM, CSWI, AVNT, MEOH, NGVT, BAK, and PRM
Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include ICL Group (ICL), Axalta Coating Systems (AXTA), Element Solutions (ESI), Arcadium Lithium (ALTM), CSW Industrials (CSWI), Avient (AVNT), Methanex (MEOH), Ingevity (NGVT), Braskem (BAK), and Perimeter Solutions (PRM). These companies are all part of the "chemicals" industry.
Chemours vs.
Chemours (NYSE:CC) and ICL Group (NYSE:ICL) are both mid-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.
ICL Group has a net margin of 5.83% compared to Chemours' net margin of 1.51%. Chemours' return on equity of 26.54% beat ICL Group's return on equity.
Chemours has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500. Comparatively, ICL Group has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.
76.3% of Chemours shares are owned by institutional investors. Comparatively, 13.4% of ICL Group shares are owned by institutional investors. 0.5% of Chemours shares are owned by insiders. Comparatively, 0.3% of ICL Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Chemours presently has a consensus target price of $23.11, suggesting a potential upside of 63.50%. ICL Group has a consensus target price of $6.75, suggesting a potential upside of 14.70%. Given Chemours' stronger consensus rating and higher probable upside, analysts plainly believe Chemours is more favorable than ICL Group.
ICL Group has higher revenue and earnings than Chemours. ICL Group is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.
Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 7.1%. ICL Group pays an annual dividend of $0.16 per share and has a dividend yield of 2.7%. Chemours pays out 175.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ICL Group pays out 50.0% of its earnings in the form of a dividend.
Chemours received 384 more outperform votes than ICL Group when rated by MarketBeat users. Likewise, 60.71% of users gave Chemours an outperform vote while only 55.53% of users gave ICL Group an outperform vote.
In the previous week, Chemours had 2 more articles in the media than ICL Group. MarketBeat recorded 8 mentions for Chemours and 6 mentions for ICL Group. ICL Group's average media sentiment score of 1.11 beat Chemours' score of 0.66 indicating that ICL Group is being referred to more favorably in the news media.
Summary
Chemours beats ICL Group on 13 of the 20 factors compared between the two stocks.
Get Chemours News Delivered to You Automatically
Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chemours Competitors List
Related Companies and Tools
This page (NYSE:CC) was last updated on 3/23/2025 by MarketBeat.com Staff
Buy CC Stock Free CC Stock Alerts